XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss) (Net of Taxes)
Accumulated Other Comprehensive Income (Loss) (Net of Taxes)
Cumulative Effect, Period of Adoption, Adjusted Balance
Balance (in shares) at Dec. 31, 2021       11,916,651            
Balance at Dec. 31, 2021 $ 247,845     $ 66,820   $ 173,393     $ 7,632  
Net income 26,645         26,645        
Other comprehensive loss, net of tax (88,859)               (88,859)  
Restricted stock granted, net of forfeitures (in shares)       42,399            
Stock issued under employee stock purchase plan (in shares)       13,351            
Stock issued under employee stock purchase plan 216     $ 216            
Stock awarded to employees (in shares)       13,446            
Stock-based compensation expense 776     $ 776            
Cash dividend $ (5,638)         (5,638)        
Stock options exercised (in shares) 50,205     50,205            
Stock options exercised $ 489     $ 489            
Repurchase and retirement of common stock (in shares)       (300,761)            
Repurchase and retirement of common stock (6,814)     $ (6,814)            
Balance (in shares) at Dec. 31, 2022       11,735,291 11,735,291          
Balance at Dec. 31, 2022 174,660 $ (3,731) $ 170,929 $ 61,487 $ 61,487 194,400 $ (3,731) $ 190,669 (81,227) $ (81,227)
Net income 25,536         25,536        
Other comprehensive loss, net of tax 15,193               15,193  
Restricted stock granted, net of forfeitures (in shares)       58,467            
Stock issued under employee stock purchase plan (in shares)       13,973            
Stock issued under employee stock purchase plan 206     $ 206            
Stock-based compensation expense 858     $ 858            
Cash dividend (5,657)         (5,657)        
Repurchase and retirement of common stock (in shares)       (39)            
Repurchase and retirement of common stock (1)     $ (1)            
Balance (in shares) at Dec. 31, 2023       11,818,039            
Balance at Dec. 31, 2023 207,064     $ 62,550   210,548     (66,034)  
Net income 7,666         7,666        
Other comprehensive loss, net of tax 10,919               10,919  
Stock issued for acquisition (in shares)       7,037,202            
Stock issued for acquisition 143,712     $ 143,712            
Restricted stock granted, net of forfeitures (in shares)       68,702            
Stock issued under employee stock purchase plan (in shares)       15,504            
Stock issued under employee stock purchase plan 248     $ 248            
Stock-based compensation expense 879     $ 879            
Cash dividend $ (8,230)         (8,230)        
Stock options exercised (in shares) 37,289     37,289            
Stock options exercised $ 465     $ 465            
Repurchase and retirement of common stock (in shares)       (2,089)            
Repurchase and retirement of common stock (38)     $ (38)            
Balance (in shares) at Dec. 31, 2024       18,974,647            
Balance at Dec. 31, 2024 $ 362,685     $ 207,816   $ 209,984     $ (55,115)